| PERIOD ENDING | 2-Oct-09 | 3-Apr-09 | 2-Jan-09 | 26-Sep-08 | | Total Revenue | 1,203,000 | 4,252,800 | 1,523,400 | 1,367,700 | | Cost of Revenue | 812,100 | 2,941,900 | 1,061,200 | 928,400 | | | Gross Profit | 390,900 | 1,310,900 | 462,200 | 439,300 | | | Operating Expenses | | Research Development | 212,100 |
-
| 476,900 |
-
| | Selling General and Administrative |
-
| 719,200 | (240,300) | 240,300 | | Non Recurring |
-
| 301,000 | 301,000 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 178,800 | 290,700 | (75,400) | 199,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 200 | 3,700 | 500 | (6,400) | | Earnings Before Interest And Taxes | 179,000 | 294,400 | (74,900) | 192,600 | | Interest Expense | 18,200 | 41,000 | 14,500 | 13,100 | | Income Before Tax | 160,800 | 253,400 | (89,400) | 179,500 | | Income Tax Expense | 56,300 | 214,200 | 87,000 | 61,400 | | Minority Interest |
-
| 155,100 | 137,800 | 600 | | | | Net Income From Continuing Ops | 104,500 | 194,300 | (38,600) | 118,700 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 104,500 | 194,300 | (38,600) | 118,700 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $104,500 | $194,300 | ($38,600) | $118,700 |
|
0.11% Nasdaq 0.00%
Income Statement
